Literature DB >> 24345007

Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention.

Daniel R Perez1, Nancy E Kemeny, Karen T Brown, Alexandra N Gewirtz, Philip B Paty, William R Jarnagin, Michael I D'Angelica.   

Abstract

BACKGROUND: Hepatic arterial infusion (HAI) chemotherapy is an effective treatment for patients with liver malignancy. Extrahepatic perfusion (EHP) after HAI pump placement requires correction prior to starting chemotherapy. The aim of this study was to define the origin of arterial branches causing EHP in order to determine if alterations in surgical technique during pump placement might prevent EHP.
METHODS: A prospectively maintained, single-centre HAI database was reviewed for all patients (2008-2011) with EHP. The origin of arterial branches causing EHP was classified anatomically and patient outcomes were analysed.
RESULTS: Of the 327 patients with pumps implanted, 24 evidenced EHP. The arterial branch responsible for EHP perfused the duodenum, pancreas and/or stomach. The branch responsible for EHP arose from the proper hepatic artery (PHA), 1(st) , 2(nd) , or 3(rd) order hepatic artery branches in 7, 10, 5 and 2 patients, respectively. The majority of branches beyond the PHA causing EHP (13/17) originated from the right hepatic artery. In 18 patients, aberrant branches were successfully treated with embolization.
CONCLUSION: These findings provide the anatomic basis for prevention of up to one-third of the cases of EHP intra-operatively, decreasing the number of patients who will require additional procedures for correction of EHP post-operatively.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24345007      PMCID: PMC4113257          DOI: 10.1111/hpb.12208

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

1.  Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients.

Authors:  Anne M Covey; Lynn A Brody; Mary A Maluccio; George I Getrajdman; Karen T Brown
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

2.  Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients.

Authors:  Soon-Young Song; Jin Wook Chung; Hyung Guhn Lim; Jae Hyung Park
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

3.  Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage.

Authors:  K T Brown; N Kemeny; M F Berger; G I Getrajdman; T Napp; Y Fong; S Herman; R C Kurtz; J Botet; L H Blumgart
Journal:  J Vasc Interv Radiol       Date:  1997 Mar-Apr       Impact factor: 3.464

4.  The management of variant arterial anatomy during hepatic arterial infusion pump placement.

Authors:  Peter J Allen; Alexander Stojadinovic; Leah Ben-Porat; Mithat Gonen; David Kooby; Leslie Blumgart; Philip Paty; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

5.  Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.

Authors:  Kaori Ito; Hiromichi Ito; Nancy E Kemeny; Mithat Gonen; Peter J Allen; Philip B Paty; Yuman Fong; Ronald P Dematteo; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2011-10-12       Impact factor: 5.344

6.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

7.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors:  A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

8.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

Authors:  Nancy E Kemeny; Donna Niedzwiecki; Donna R Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Journal:  J Clin Oncol       Date:  2006-02-27       Impact factor: 44.544

9.  Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.

Authors:  Peter J Allen; Aviram Nissan; Antonio I Picon; Nancy Kemeny; Paul Dudrick; Leah Ben-Porat; Joseph Espat; Alexander Stojadinovic; Alfred M Cohen; Yuman Fong; Philip B Paty
Journal:  J Am Coll Surg       Date:  2005-07       Impact factor: 6.113

Review 10.  Arterial therapy of hepatic colorectal metastases.

Authors:  J N Vauthey; R de W Marsh; J C Cendan; N M Chu; E M Copeland
Journal:  Br J Surg       Date:  1996-04       Impact factor: 6.939

View more
  3 in total

Review 1.  Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Authors:  Alexandre Doussot; Nancy E Kemeny; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2015-07-27

2.  Nuclear imaging in the identification of aberrant vascular anatomy prior to hepatic arterial infusion.

Authors:  Tristan R Lawson; Jennifer A Schroeder
Journal:  Radiol Case Rep       Date:  2022-04-23

Review 3.  Hepatic artery infusion pumps.

Authors:  Cornelius A Thiels; Michael I D'Angelica
Journal:  J Surg Oncol       Date:  2020-03-25       Impact factor: 2.885

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.